Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines

Overview of attention for article published in PharmacoEconomics, May 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

policy: 2 policy sources

twitter: 18 X users

Citations

dimensions_citation: 84 Dimensions

Readers on

mendeley: 151 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 3 policy documents that reference this research output.

Understanding the institutions of domestic health financing decisions: insights from immunisation services in three low- and middle-income countries

Cited by Overseas Development Institute on 28 Sep 2022

ODI is an independent, global think tank, working for a sustainable and peaceful world in which every person thrives.

Evaluating the quality and use of economic data in decisions about essential medicines

Cited by World Health Organization on 26 Mar 2018

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Guidance on the economic evaluation of influenza vaccination

Cited by World Health Organization on 12 Sep 2016

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.